- Home
- ICMB vs SYRS Comparison
ICMB vs SYRS Comparison
Compare ICMB & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- SYRS
- Stock Information
- Founded
- ICMB 2012
- SYRS 2011
- Country
- ICMB United States
- SYRS United States
- Employees
- ICMB N/A
- SYRS N/A
- Industry
- ICMB Finance: Consumer Services
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- ICMB Finance
- SYRS Health Care
- Exchange
- ICMB Nasdaq
- SYRS Nasdaq
- Market Cap
- ICMB 48.0M
- SYRS 52.5M
- IPO Year
- ICMB N/A
- SYRS 2016
- Fundamental
- Price
- ICMB $3.28
- SYRS $1.97
- Analyst Decision
- ICMB
- SYRS Strong Buy
- Analyst Count
- ICMB 0
- SYRS 3
- Target Price
- ICMB N/A
- SYRS $5.00
- AVG Volume (30 Days)
- ICMB 33.6K
- SYRS 162.2K
- Earning Date
- ICMB 11-11-2024
- SYRS 11-12-2024
- Dividend Yield
- ICMB 14.68%
- SYRS N/A
- EPS Growth
- ICMB N/A
- SYRS N/A
- EPS
- ICMB N/A
- SYRS N/A
- Revenue
- ICMB $23,878,302.00
- SYRS $4,149,000.00
- Revenue This Year
- ICMB $10.32
- SYRS N/A
- Revenue Next Year
- ICMB N/A
- SYRS $614.29
- P/E Ratio
- ICMB N/A
- SYRS N/A
- Revenue Growth
- ICMB N/A
- SYRS N/A
- 52 Week Low
- ICMB $2.98
- SYRS $1.43
- 52 Week High
- ICMB $3.97
- SYRS $8.17
- Technical
- Relative Strength Index (RSI)
- ICMB 65.56
- SYRS 45.77
- Support Level
- ICMB $3.14
- SYRS $1.90
- Resistance Level
- ICMB $3.23
- SYRS $2.01
- Average True Range (ATR)
- ICMB 0.07
- SYRS 0.11
- MACD
- ICMB 0.01
- SYRS 0.04
- Stochastic Oscillator
- ICMB 94.49
- SYRS 26.67
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.